Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)
NCT02244333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4575
Last updated 2014-09-19
Summary
Study to assess efficacy, tolerability and safety parameters of a one month ALNA® - treatment after switch from Terazosin-treatment
Conditions
- Prostatic Hyperplasia
Interventions
- DRUG
-
ALNA®
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2004-07-31
More Related Trials
-
Benign Prostatic Hyperplasia in Taiwan
NCT00941343 ·Status: COMPLETED ·Phase: NA
-
The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
NCT00224133 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
NCT02245555 ·Status: COMPLETED
-
Clinical Outcomes of Laser Prostatectomy
NCT03318991 ·Status: UNKNOWN ·Phase: NA
-
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
NCT00224120 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia
NCT06689514 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia
NCT00894517 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
NCT00224107 ·Status: COMPLETED ·Phase: PHASE3
-
A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
NCT01275521 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression
NCT01716104 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System
NCT06965582 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
NCT00044226 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
NCT02431754 ·Status: COMPLETED ·Phase: PHASE4
-
ALF-ONE : ALFuzosin ONcE Daily
NCT00280605 ·Status: COMPLETED ·Phase: PHASE4
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA
-
Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)
NCT01259531 ·Status: COMPLETED ·Phase: PHASE4
-
Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia
NCT02313233 ·Status: COMPLETED ·Phase: NA
-
The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score
NCT00540891 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Outcomes and Ejaculatory Function in BPO Patients Treated With Silodosin
NCT06989515 ·Status: NOT_YET_RECRUITING
-
Clinical Trial in Males With BPH (Enlarged Prostate)
NCT00029822 ·Status: COMPLETED ·Phase: PHASE3
-
Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction
NCT03653117 ·Status: COMPLETED ·Phase: NA
-
A Study in Men With Benign Prostatic Hyperplasia
NCT01097707 ·Status: TERMINATED ·Phase: PHASE2
-
Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA
NCT04760483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
NCT05558007 ·Status: RECRUITING ·Phase: PHASE2
-
A Comparative Study of KSO-0400 in BPH Patients With LUTS
NCT01222650 ·Status: COMPLETED ·Phase: PHASE2